MarketCap
Facebook
X
TelegramQuarterly report 2023-Q4
added 02-12-2024
Nemaura Medical Cash and Cash Equivalents 2011-2026 | NMRD
Annual Cash and Cash Equivalents Nemaura Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.1 M | 17.7 M | 31.9 M | 106 K | 3.74 M | 822 K | 911 K | 9.4 M | 355 K | 1.87 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.9 M | 106 K | 7.69 M |
Quarterly Cash and Cash Equivalents Nemaura Medical
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 K | 1.38 M | 4.01 M | 10.1 M | 7.34 M | 10.1 M | 14.8 M | 17.7 M | 23 M | 26.8 M | 31.3 M | 31.9 M | 15 M | 15 M | 16.9 M | 5.95 M | 1.07 M | 1.07 M | 1.77 M | 3.07 M | 5.04 M | 526 K | 320 K | 822 K | 1.66 M | 598 K | 1.28 M | 911 K | 7.59 M | 8.32 M | 8.49 M | 9.4 M | 9.85 M | 99.8 K | 126 K | 355 K | 614 K | 907 K | 1.11 M | 1.87 M | 6.83 K | 28.3 K | 17.4 K | 200 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.9 M | 6.83 K | 6.78 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.11 | - | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 10.42 | - | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Butterfly Network
BFLY
|
88.8 M | $ 3.91 | - | $ 828 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 37.41 | - | $ 1.16 B | USA |
 |
Alphatec Holdings
ATEC
|
161 M | $ 12.6 | - | $ 1.89 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 8.38 | - | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 B | $ 69.79 | - | $ 103 B | USA |
 |
Establishment Labs Holdings
ESTA
|
75.6 M | $ 63.48 | - | $ 1.88 B |  Costa-rica |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.19 | - | $ 1.33 M | USA |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.33 | - | $ 21.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 11.03 | - | $ 298 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
636 M | $ 61.43 | - | $ 3.35 B |  Britain |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
46.8 M | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
68.9 M | $ 13.43 | - | $ 868 M | Israel |
 |
MiMedx Group
MDXG
|
166 M | $ 4.41 | - | $ 652 M | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
213 M | $ 2.59 | - | $ 152 M | Israel |
 |
Abbott Laboratories
ABT
|
8.52 B | $ 109.95 | - | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.81 | - | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 261.24 | - | $ 7.37 B | USA |
 |
Insulet Corporation
PODD
|
716 M | $ 224.66 | - | $ 15.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 9.01 | - | $ 694 M | USA |
 |
Profound Medical Corp.
PROF
|
26.2 M | $ 5.71 | - | $ 180 M | Canada |
 |
AxoGen
AXGN
|
35.5 M | $ 32.84 | - | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 169.45 | - | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 32.76 | - | $ 4.88 K | USA |
 |
AVITA Medical
RCEL
|
10.2 M | $ 4.62 | 5.0 % | $ 129 M |  Australia |